Panagora Asset Management Inc Novo Cure LTD Transaction History

Panagora Asset Management Inc

$20.5 Billion
Q3 2024

A detailed history of Panagora Asset Management Inc transactions in Novo Cure LTD stock. As of the latest transaction made, Panagora Asset Management Inc holds 349,811 shares of NVCR stock, worth $5.64 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

349,811

Previous 409,794 14.64%

Holding current value

$5.64 Million

Previous $7.02 Million 22.11%

% of portfolio

0.03%

Previous 0.04%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$15.61 - $23.34 $936,334 - $1.4 Million	-59,983 Reduced 14.64%	349,811 $5.47 Million
Q2 2024 Jul 29, 2024	BUY	$11.83 - $24.05 $3.66 Million - $7.45 Million	309,805 Added 309.84%	409,794 $7.02 Million
Q1 2024 May 07, 2024	BUY	$12.42 - $17.29 $1.24 Million - $1.73 Million	99,989 New	99,989 $1.56 Million
Q2 2023 Aug 11, 2023	BUY	$40.29 - $82.51 $266,518 - $545,803	6,615 Added 55.64%	18,503 $767,000
Q1 2023 May 11, 2023	SELL	$56.44 - $118.81 $12,078 - $25,425	-214 Reduced 1.77%	11,888 $714,000
Q4 2022 Feb 13, 2023	SELL	$63.98 - $85.37 $38,388 - $51,222	-600 Reduced 4.72%	12,102 $887,000
Q1 2022 May 12, 2022	BUY	$60.15 - $84.52 $563,364 - $791,614	9,366 Added 280.76%	12,702 $1.05 Million
Q4 2021 Feb 10, 2022	SELL	$75.08 - $121.99 $65,169 - $105,887	-868 Reduced 20.65%	3,336 $250,000
Q2 2021 Aug 11, 2021	SELL	$130.4 - $225.58 $62,200 - $107,601	-477 Reduced 10.19%	4,204 $933,000
Q1 2021 May 12, 2021	SELL	$124.11 - $190.17 $1.06 Million - $1.63 Million	-8,551 Reduced 64.62%	4,681 $619,000
Q4 2020 Feb 10, 2021	BUY	$112.16 - $174.14 $368,782 - $572,572	3,288 Added 33.07%	13,232 $2.29 Million
Q3 2020 Nov 13, 2020	BUY	$58.05 - $111.31 $11,203 - $21,482	193 Added 1.98%	9,944 $1.11 Million
Q2 2020 Aug 12, 2020	SELL	$57.2 - $74.41 $3.62 Million - $4.71 Million	-63,309 Reduced 86.65%	9,751 $578,000
Q1 2020 May 14, 2020	SELL	$57.05 - $95.75 $1.58 Million - $2.65 Million	-27,711 Reduced 27.5%	73,060 $4.92 Million
Q4 2019 Feb 12, 2020	BUY	$68.3 - $93.8 $6.39 Million - $8.77 Million	93,520 Added 1289.75%	100,771 $8.49 Million
Q3 2019 Nov 12, 2019	BUY	$61.86 - $97.8 $448,546 - $709,147	7,251 New	7,251 $542,000

Others Institutions Holding NVCR

# of Institutions

262

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.69B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Panagora Asset Management Inc with notifications on news.

Account

Panagora Asset Management Inc Novo Cure LTD Transaction History